Abstract Search

ea0029p902 | Female Reproduction | ICEECE2012

The effects of the therapy with ethinylestradiol 30 μg-drospirenone+metformin on endothelial dysfunction in the polycystic ovary syndrome

Ilie I. , Ilie R. , Marian I. , Mocan T. , Hazi G. , Duncea I. , Georgescu C.

Introduction: Recent data indicate that women affected by the polycystic ovary syndrome (PCOS) are at a greater risk for cardiovascular disease (CVD). The objective of this study was to evaluate the effect of the association ethinylestradiol 30 μgdrospirenone 3 mg (DRP/EE30 μg) plus metformin and weight loss on surrogate markers of CVD in PCOS.Methods: Twenty-five young women with PCOS (mean age 22.76±0.83 years, body mass index (BMI...

0 shares

ea0026p561 | Cardiovascular endocrinology and lipid metabolism | ECE2011

Young women with the polycystic ovary syndrome (PCOS) have evidence of endothelial dysfunction but not of altered arterial structure

Duncea I , Ilie I R , Georgescu C , Marian I , Mocan T , Man B , Brad C , Hazi G

Aim: The aim of our study was to assess the presence of endothelial dysfunction and of increased carotid intimae-media thickness (IMT), two precocious markers of atherosclerosis in PCOS subjects. Simultaneously, their relationship with some metabolic, hormonal and anthropometric parameters was analyzed.Methods: The study group consisted of 45 women with PCOS (age=23.1±4.1 years, body mass index (BMI) =28.4±5.9 kg/m2). Thirty-two heal...

0 shares

Endocrine Abstracts

The effects of the therapy with ethinylestradiol 30 μg-drospirenone+metformin on endothelial dysfunction in the polycystic ovary syndrome

Young women with the polycystic ovary syndrome (PCOS) have evidence of endothelial dysfunction but not of altered arterial structure

BiosciAbstracts